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Abstract
Background: Quantitative flow ratio (QFR) is a novel approach to derive fractional flow reserve (FFR) 
from coronary angiography. This study sought to evaluate the reproducibility of QFR when analyzed in 
independent core laboratories.
Methods: All interrogated vessels in the FAVOR II China Study were separately analyzed using the 
AngioPlus system (Pulse medical imaging technology, Shanghai) by two independent core laboratories, 
following the same standard operation procedures. The analysts were blinded to the FFR values and 
online QFR values. For each interrogated vessel, two identical angiographic image runs were used by 
two core laboratories for QFR computation. In both core laboratories QFR was successfully obtained in 
330 of 332 vessels, in which FFR was available in 328 vessels. Thus, 328 vessels ended in the present 
statistical analysis. 
Results: The mean difference in contrast-flow QFR between the two core laboratories was 0.004 ± 
0.03 (p = 0.040), which was slightly smaller than that between the online analysis and the two core 
laboratories (0.01 ± 0.05, p < 0.001 and 0.01 ± 0.05, p = 0.038). The mean difference of QFR with 
respect to FFR were comparable between the two core laboratories (0.002 ± 0.06, p = 0.609, and 0.002 
± 0.06, p = 0.531). Receiver operating characteristic curve analysis showed that diagnostic accuracies 
of QFR analyzed by the two core laboratories were both excellent (area under the curve: 0.970 vs. 0.963, 
p = 0.142), when using FFR as the reference standard.
Conclusions: The present study showed good inter-core laboratory reproducibility of QFR in assessing 
functionally-significant stenosis. It suggests that QFR analyses can be carried out in different core labo-
ratories if, and only if, highly standardized conditions are maintained. (Cardiol J XXXX; XX, X: xx–xx)
Key words: quantitative flow ratio, fractional flow reserve, reproducibility,  
core laboratories, coronary stenosis
Introduction
Revascularization strategies of stable coronary 
artery disease (CAD) have relied largely on non-
invasive stress tests and coronary angiography 
in current practice [1]. For decades physiologic 
evaluation of myocardial perfusion has been pro-
posed and experimented with as a potential tool 
to determine the ischemic severity of coronary 
artery stenosis. However, it was not until recent 
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years, after the invention of clinically feasible 
tools, that physiological assessment of coronary 
blood flow could be adopted to guide interventions. 
Coronary fractional flow reserve (FFR) acquired 
by a pressure-wire placed within target coronary 
vessels can assist in decision making for interme-
diate lesions during coronary intervention, with 
proven clinical and economic benefits [2–5]. A FFR 
value of ≤ 0.80 indicates a functionally significant 
stenosis [6]. The European Society of Cardiology 
has recommended this procedure as class I level A 
for the CAD revascularization approach [7]. Nev-
ertheless, widespread utilization of FFR is limited 
by its invasive nature, relatively high cost and use 
of medication to achieve hyperemia states which 
may introduce complications or adverse events. 
A real-world survey reveals that FFR is used in 
less than 10% of intermediate coronary lesions 
(40–70% stenosis) [8]. 
Quantitative flow ratio (QFR) is a novel angio­
graphy-based computation to derive FFR using 
computer algorithms that omits the need for pres-
sure guidewire and vasodilator administration [9, 
10]. The entire analysis can be done in minutes 
without extra procedures during diagnostic coro-
nary angiography, making it an appealing tool to be 
used in the catheterization laboratory. The recently 
published FAVOR II China Study demonstrated 
excellent accuracy of online QFR assessment in 
the catheterization laboratories when compared 
with the standard FFR measurement. Patient-level 
and vessel-level diagnostic accuracy of contrast-
flow QFR were 92.4% (95% confidence interval 
[CI] 88.9–95.1%) and 92.7% (95% CI 89.3–95.3%), 
respectively [11]. 
In addition to the potential application in 
guiding coronary revascularization, QFR can be 
used to assess the efficacy of different stents by 
evaluating the physiological functionality of the 
coronary artery after stent implantation in a core 
laboratory setting [12]. The FAVOR II China Study 
also demonstrated that QFR showed excellent ac-
curacy when analyzed in the core laboratory [11]. 
Nevertheless, the reproducibility of QFR when 
analyzed in other core laboratories has not been 
addressed. The aim of the present study was to 
evaluate the reproducibility of QFR when analyzed 
offline in two independent core laboratories. 
Methods
Study materials
The FAVOR II China Study [11] is a prospec-
tive, multicenter study that enrolled patients who 
had at least one lesion with a diameter stenosis of 
30% to 90% and a reference diameter ≥ 2 mm by 
visual estimation. Detailed inclusion and exclusion 
criteria of the study and the patient characteristics 
have been reported in the main study. All patients 
enrolled in the study were reanalyzed in a second 
core lab (CardHemo, Med-X Research Institute, 
Shanghai Jiao Tong University, Shanghai, China), 
hereafter noted as CoreLab2. The reference FFR 
values and the QFR values by the first core lab 
(CCRF, Beijing, China), hereafter noted as Core-
Lab1, were taken from the main study [11] to 
assess the inter-core laboratories variability and 
the difference in diagnostic accuracy by different 
core laboratories, when using FFR as the reference 
standard. The study procedure was approved by the 
institutional review board. All patients provided 
written informed consent.
QFR core-lab analysis
All QFR analyses in the CoreLab2 were per-
formed by an experienced analyst (CY), following 
the same standard operation procedures (SOP) and 
by the AngioPlus system (Pulse medical imaging 
technology, Shanghai) as used by the CoreLab1. 
The analyst was blinded to the FFR values and 
the previously computed QFR values. For each 
interrogated vessel, the two identical angiographic 
image runs were used by the two core laboratories 
for QFR computation. The interrogated vessels 
were reconstructed based on two angiographic im-
age runs with minimal overlap and foreshortening 
that were acquired with ≥ 25° difference in projec-
tion angles. Subsequently, the analyst performed 
modified frame count on one of the angiographic 
runs to obtain the mean contrast flow velocity, 
from which the computer modeled the hyperemic 
flow velocity and computed the contrast­flow QFR 
for the entire vessel. This methodology has been 
previously reported [9, 10]. In the same procedure, 
the computer used a fixed contrast flow velocity 
to derive the fixed­flow QFR (fQFR) [10]. Prior to 
QFR computation, the interrogated vessels and the 
segments where FFR was measured and reported 
to the analyst. However, the image frames used for 
three-dimensional (3D) angiographic reconstruc-
tion and the image runs used for modified frame 
count were selected by the analyst following SOP, 
being blinded to the online and the CoreLab1 se-
lection results. Contour of the vessel lumen was 
first automatically delineated by the QFR measure-
ment system and manual adjustment was allowed 
following SOP in case of suboptimal angiographic 
image quality.
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Statistical analysis
Continuous variables were depicted as mean 
± standard deviation unless otherwise stated. The 
D’Agostino Pearson test was used to test normal 
distribution of the data. Pair-wise comparisons of 
different QFR analyses were assessed using Bland-
Altman plots. The correlation between FFR and 
QFR was evaluated using the Pearson or Spearman 
correlation tests as appropriate. An FFR test ≤ 
0.80 was considered for diagnosis of hemodynam-
ically­significance. Sensitivity, specificity, positive 
predictive value (PPV), negative predictive value 
(NPV), positive likelihood ratio (+LR), negative 
likelihood ratio (–LR) of QFR with the FFR as the 
reference standard were calculated and the 95% 
CIs were added, as appropriate. The Student t test 
or Mann-Whitney U tests were performed for pair-
wise comparisons. Receiver operator characteristic 
(ROC) curves were compared using the DeLong 
method. All statistical analyses were performed 
using MedCalc 14.12.0 (MedCalc Software, Mari-
akerke, Belgium). A two-sided p value of < 0.05 
was considered statistically significant.
Results
In both core laboratories QFR and fQFR were 
successfully obtained in 330 of 332 interrogated 
vessels, in which FFR was available in 328 vessels 
from 304 patients. Thus, pairwise comparisons 
were performed in 328 vessels. 
Correlation and agreement of QFR analysis 
The computed QFR values by the two core 
laboratories demonstrated better correlations 
(r = 0.96 vs. 0.91, p < 0.001) and agreement (0.004 
± 0.03 vs. –0.01 ± 0.05, p < 0.001) than those by 
CoreLab2 and online analyses (Fig. 1). Similarly, 
computed fQFR by the two core laboratories had 
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Figure 1. A–D. Correlation and agreement between quantitative flow ratio (QFR) analysis of CoreLab1 and CoreLab2, 
Online and CoreLab2; SD — standard deviation.
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and agreement (0.01 ± 0.04 vs. 0.003 ± 0.05, 
p < 0.001) than those by CoreLab2 and online anal-
yses (Fig. 2). The computed QFR values by the two 
core laboratories demonstrated better correlations 
(r = 0.96 vs. 0.91, p < 0.001) and agreement (0.004 
± 0.03 vs. –0.01 ± 0.05, p < 0.001) than those by 
CoreLab1 and the online analyses reported in the 
FAVOR II China Study [11].
Correlation and agreement  
between FFR and QFR analysis 
For CoreLab2 analyses, both QFR and fQFR 
had good correlations with FFR, with the Spearman 
correlation coefficients being significantly higher 
for QFR than fQFR measurements (0.86 vs. 0.79, 
p < 0.001). Both QFR and fQFR had good agree-
ment with FFR, with a slightly smaller error for 
QFR than fQFR (0.002 ± 0.06, vs. 0.01 ± 0.08, 
p < 0.001) (Fig. 3). The mean difference of QFR 
with respect to FFR were comparable between the 
two core laboratories (0.0016 ± 0.06 vs. 0.0021 ± 
0.06, p = 0.915).
Diagnostic performance of QFR and fQFR 
using FFR as the reference standard
ROC analyses show that QFR analyzed by the 
two core laboratories had comparable diagnostic 
performance, with areas under curve (AUC) being 
0.970 and 0.963 (p = 0.142). The fQFR analyzed 
by the second core laboratory also had comparable 
but statistically significant AUC as the first core 
laboratory (0.950 vs. 0.935, p = 0.047) (Fig. 4).
Using FFR as the reference standard, the over-
all accuracy, sensitivity and specificity in diagnosis 
of hemodynamically­significant stenosis were all 
excellent for CoreLab2 (accuracy: 92.07% [95% CI 
89.13–95.01%], sensitivity: 94.96% [95% CI 89.3–
98.1%], specificity: 89.95% [95% CI 85.1–93.7%]), 
and those were comparable with CoreLab1 (ac-
curacy: 93.3% [95% CI 90.0–95.7%], sensitivity: 
Figure 2. A–D. Correlation and agreement between fixed-flow quantitative flow ratio (fQFR) analysis of CoreLab1 and 
CoreLab2, Online and CoreLab2; SD — standard deviation.
www.cardiologyjournal.org 5


























































r = 0.86; p < 0.001



































Mean of FFR and QFR
Mean of FFR and fQFR
Mean difference: 0.002, SD: 0.06, p = 0.531A
C
B























CoreLab1 QFR; AUC 0.970 [95% CI: 0.945, 0.986]
CoreLab2 QFR: AUC 0.963 [95% CI: 0.936, 0.981]
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Figure 3. Correlation and agreement between fractional flow reserve (FFR) and quantitative flow ratio (QFR) analysis 
of CoreLab2 (A, B). Correlation and agreement between FFR and fixed-flow QFR analysis of CoreLab2 (C, D). 
Figure 4. Comparison of receiver operating curves for the quantitative flow ratio (QFR) (A) and fixed-flow QFR (fQFR) 
(B) results of CoreLab1 and CoreLab2. QFR analyzed by the two core laboratories had comparable diagnostic per-
formance. Fractional flow reserve was used as the reference standard; AUC — area under curve; CI — confidence 
interval.
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94.1% [95% CI 88.3–97.6%], specificity: 92.8% 
[95% CI 88.4–95.9%]) as previously reported [11]. 
PPV, NPV, +LR and –LR for CoreLab2 was 84.3, 
96.9, 9.45 and 0.056, respectively. 
Discussion
This is the first study to report on the inter­
corelab variation for QFR computation. The key 
finding was that QFR is reproducible and provides 
comparable diagnostic accuracy with FFR as a ref-
erence standard when analyzed by two independent 
core laboratories using the same dedicated SOP. It 
supports the use of QFR for evaluation of coronary 
physiology in a core laboratory setting.
The study focused on the technical and observ-
er-dependent variation since user-interactions are 
needed to refine geometrical parameters of vessels 
and select an appropriate frame for contrast flow 
velocity assessment. It showed herein, that very 
similar QFR results could be acquired in different 
core laboratories when the analysts strictly fol-
lowed SOP and that the extra frame-counting step 
needed to compute QFR compared to fQFR did not 
influence reproducibility. 
Fractional flow reserve has emerged as the 
current gold standard to guide percutaneous 
coronary interventions by improving outcome 
compared to angiography-guided percutaneous 
coronary intervention in multiple clinical trials [6, 
7, 13, 14]. Apart from the favorable clinical out-
comes, FFR appears solid in terms of reproducibil-
ity. The absolute difference and standard deviation 
of repeated FFR measurements approaches 0.03 ± 
0.02 as illustrated in the Fractional Flow Reserve 
to Determine the Appropriateness of Angioplasty 
in Moderate Coronary Stenosis A Randomized 
Trial (DEFER) where repeated FFR measure-
ments were performed in 325 patients [15]. Ap-
plication of the “smart minimum” algorithm to 
The Verification of Instantaneous Wave­Free Ratio 
and Fractional Flow Reserve for the Assessment 
of Coronary Artery Stenosis in Everyday Practice 
(VERIFY) study likewise found good repeatability 
of FFR (0.00 ± 0.02) [16]. The minor variability 
may be caused by several factors related to fluc-
tuating hemodynamics, suboptimal vasodilation, 
drift and variation of wire-position. The presented 
inter-corelab variation for QFR of 0.00 ± 0.03 is 
in the same range as FFR and adds to the exist-
ing knowledge with multiple off-line and on-line 
studies proving high diagnostic accuracy of QFR 
when FFR is used as a reference standard [9–11, 
17–23]. The present results confirm findings from 
a pilot study conducted by van Rosendael et al. [24] 
that presented an inter-observer variation of 0.02 
± 0.04 for QFR in a limited number of 20 lesions. 
Importantly, the present results are improved 
when compared to QFR intra-observer agreement 
of 0.00 ± 0.06 in 40 lesions, as recently reported 
by Westra et al. [19]. This is most likely due to 
a more refined SOP for image acquisition, better 
angiographic quality and a more elaborate protocol 
for QFR analysis. Further, results were marginally 
better than on-line QFR results in the FAVOR II 
China Study [11], which may be explained by mul-
tiple factors. In the on­line analyses, five centres 
participated in FAVOR II China Study [11] with 
their own technicians performing all measure-
ments. Although highly skilled, inter-personnel 
differences may have contributed to slight varia-
tions. Further, time to QFR was recorded in the 
FAVOR II China Study [11]. Although this was not 
used for comparison, site staff facing time pressure 
to execute the measurements may have resulted 
in a minor bias.
Limitations of the study
This study has certain limitations. Firstly, 
intra-observer variation was not assessed. Sec-
ondly, despite the presented comparison of core-lab 
specific diagnostic accuracy estimates with FFR, 
it should be noted that this study does not report 
on true repeated QFR measurements since two 
independent core-labs used the same datasets to 
compute QFR at two different time-points. Hence, 
the biological variability of repeated QFR compu-
tation was not assessed. However, the majority of 
data on repeated FFR derives from repeated FFR 
measurements in the same patient within a small 
time-frame which likewise limits the evaluation of 
biological variability. Thirdly, optimal angiographic 
quality is crucial for optimal QFR computation. 
Since the repeated measurements were all per-
formed on the same high­quality angiographic runs, 
the variation caused by potential suboptimal image 
quality was not included. 
Conclusions
The present study showed good inter-core 
laboratory reproducibility for QFR in assessing the 
physiological significance of coronary stenosis. It 
suggests that QFR analyses can be carried out in 
different core laboratories if highly standardized 
operating procedures are maintained.
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